Antiphospholipid and Anti‐DNA Antibodies Are Not Associated with the Elevated Release of Circulatory Fetal DNA in Pregnancies Affected by Preeclampsia

References

• Dekker G A, Sibai B M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179(5)1359–1375, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Redman C W, Sacks G P, Sargent I L. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180(1)499–506, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Johansen M, Redman C W, Wilkins T, Sargent I L. Trophoblast deportation in human pregnancy: its relevance for preeclampsia. Placenta 1999; 20(7)531–539, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Knight M, Redman C W, Linton E A, Sargent I L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. BJOG 1998; 105(6)632–640
   Google Scholar
• Zhong X Y, Laivuori H, Livingston J C, Ylikorkala O, Sibai B M, Holzgreve W, Hahn S. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001; 184(3)414–419, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lo Y M, Tein M S, Lau T K, Haines C J, Leung T N, Poon P M. Quantitative analysis of fetal DNA in maternal plasma and serum. Am J Hum Genet 1998; 62(4)768–775, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Swinkels D W, de Kok J B, Hendriks J C, Wiegering E, Zusterzeel P, Steegers E. Hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell‐free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002; 48(4)650–653, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Leung T N, Zhang J, Lau T K, Chan L Y, Lo Y M. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47(1)137–139, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zhong X Y, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002; 21(1)77–83, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hahn S, Holzgreve W. Fetal cells and cell‐free fetal DNA in maternal blood: new insights into pre‐eclampsia. Hum Reprod Updat 2002; 8(6)501–508, [CROSSREF], [CSA]
   Google Scholar
• Branch D M, Andres R, Digre K B, Rote N S, Scott J R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73(4)541–545, [PUBMED], [INFOTRIEVE]
   Web of Science ®Google Scholar
• Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86(4)555–559, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Matthiesen L S, Berg G, Ernerudh J, Skogh T. A prospective study on the occurrence of autoantibodies in low‐risk pregnancies. Eur J Obstet, Gynecol, Reprod Biol 1999; 83(1)21–26, [CROSSREF], [CSA]
   Google Scholar
• Harris E N. Antiphospholipid antibodies. Br J Haematol 1990; 74(1)1–9, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Harris E N, Phil M. The second international anticardiolipin standardization workshop. The Kingston antiphospholipid antibody study (KAPS) group (special report). Am J Clin Pathol 1990; 94(4)474–484
   Google Scholar
• Tan E M, Fritzler M J, Hardin J A, McDougal J S. Comprehensive Report: Reference Sera for Antinuclear Antibodies I. Antibodies to Native DNA, Sm, Nuclear RNP, SS‐B/La, SS‐A/Ro, Scl‐70, Nucleoli, and Centromere/Kinetochore. Committee on antinuclear antibody serology, The Arthritis Foundation, Atlanta, GA 1984
   Google Scholar
• Bret L, Lule J, Alary C, Appolinaire‐Pilipenko S, Pourrat J P, Fournie G J. Quantification of blood plasma DNA as an index of in vivo cytotoxicity. Toxicology 1990; 61(3)283–292, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Holdenrider S, Stieber P, Forg T, Kuhl M, Schulz L, Busch M. Apoptosis in serum of patients with solid tumours. Anticancer Res 1999; 19(4A)2721–2724, [CSA]
   Google Scholar
• Giacona M B, Ruben G C, Iczkowski K A, Roos T B, Porter D M, Sorenson G D. DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998; 17(1)89–97, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kutten W H, Rote N S, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999; 41(2)133–152
   Google Scholar
• Rand J H. Antiphospholipid antibody‐mediated disruption of the annexin V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. J Autoimmun 2000; 15(2)107–111, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• De Simone N, Meroni P L, Del Papa N, Raschi E, Caliandro D, De Carolis C S, Khamashta M A, Atsumi T, Hughes G R, Balestrieri G, Tincani A, Casali P. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered β2‐glycoprotein I. Arthritis Rheum 2000; 43(1)140–150, [CROSSREF]
   Google Scholar
• Chamley L W, Duncalf A M, Mitchell M D, Johnson P M. Action of anticardiolipin and antibodies to β2‐glycoprotein I on trophoblast proliferation as a mechanism for fetal death. Lancet 1998; 352(9133)1037–1038, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Yacobi S, Ornoy A, Blumenfeld Z, Miller R. Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002; 66(6)300–308, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Milliez J, Lelong F, Bayani N, Jannet D, el Medjadji M, Latrous H, Hammami M, Paniel B J. The prevalence of autoantibodies during third‐trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 1991; 165(1)51–56, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Allen J Y, Tapia‐Santiago C, Kutteh W H. Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 1996; 36(2)81–85, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Moodley J, Bhoola V, Duursma J, Pudifin D, Birne S, Kenoyer D G. The association of antiphospholipid antibodies with severe early‐onset pre‐eclampsia. S Afr Med J 1995; 85(2)105–107, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Rao A A, Ananthakrishna N C. Anticardiolipin antibodies in eclampsia. Int J Gynaecol Obstet 1992; 38(1)37–40, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Martinez‐Abundis E, Gonzalez‐Ortiz M, Cortes‐Lamas V, Salazar‐Paramo M. Anticardiolipin antibodies and the severity of preeclampsia–eclampsia. Gynecol Obstet Investig 1999; 48(3)168–170, [CROSSREF], [CSA]
   Google Scholar
• Dreyfus M, Hedelin G, Kutnahorsky R, Lehmann M, Viville B, Langer B, Fleury A, MBarek M, Treisser A, Wiesel M L, Pasquali J L. Antiphospholipid antibodies and preeclampsia: a case‐control study. Obstet Gynecol 2001; 97(1)29–34, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Valdes‐Macho E, Cabiedes J, Villa A, Cabral A, Alarcon‐Segovia D. Anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in hypertensive disorders of pregnancy. Arch Med Res 2002; 33(5)460–465, [CROSSREF], [CSA]
   Google Scholar
• Branch D W, Porter T F, Rittenhouse L, Caritis S, Sibai B, Hogg B, Lindheimer M D, Klebanoff M, MacPherson C, VanDorsten J P, Landon M, Paul R, Miodovnik M, Meis P, Thurnau C. National Institute of child health and human development maternal–fetal medicine units network. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001; 184(5)825–834, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lynch A, Byers T, Emlen W, Rynes D, Shetterly S M, Hamman R F. Association of antibodies to β2‐Glycoprotein I with pregnancy loss and pregnancy‐induced hypertension: a prospective study in low‐risk pregnancy. Obstet Gynecol 1999; 93(2)193–198, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Aoki K, Dudkiewicz A B, Matsuura E. Clinical significance of â2‐glycoprotein I‐dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995; 172(3)926–931, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Shlomchik M, Mascelli M, Shan H, Radic M Z, Pisetsky D, Marshak‐Rothstein A, Weigert M. Anti‐DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 1990; 171(1)265–292, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaliyaperumal A, Mohan C, Wu W, Datta S K. Nucleosomal peptide epitopes for nephritis‐inducing T helper cells of murine lupus. J Exp Med 1996; 183(6)2459–2469, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Eilat D, Naparstek Y. Anti‐DNA autoantibodies: a puzzle of autoimmune phenomena. Immunol Today 1999; 20(8)339–342, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Kiuttu J, Hartikainen‐Sorri A L, Makitalo R. Occurrence of antinuclear antibodies in an unselected pregnancy population. Gynecol Obstet Investig 1992; 33(1)21–25
   Google Scholar
• Weitgasser R, Spitzer D, Kartnig I, Zajc M, Staudach A, Sandhofer F. Association of HELLP syndrome with autoimmune antibodies and glucose intolerance. Diabetes Care 2000; 23(6)786–790, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yamamoto T, Yoshimura S, Geshi Y, Sasamori Y, Mori H, Kobayashi T. Anti‐ssDNA and dsDNA antibodies in preeclampsia. Asia‐Oceania J Obstet Gynaecol 1994; 20(1)93–99, [CSA]
   Google Scholar